Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,316 | 60,711 | 53,424 | 126,950 | 113,056 |
| Depreciation Amortization | 85,269 | 90,888 | 50,514 | 31,833 | 18,333 |
| Income taxes - deferred | -25,714 | -26,324 | -4,994 | 568 | -5,832 |
| Accounts receivable | 18,765 | -16,366 | 3,867 | -34,607 | 15,751 |
| Other Working Capital | -9,137 | -24,243 | 3,570 | -36,515 | 801 |
| Other Operating Activity | 40,586 | 32,160 | 20,746 | 50,170 | 1,020 |
| Operating Cash Flow | $111,085 | $116,826 | $127,127 | $138,399 | $143,129 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 269,280 | -216,251 | 218,936 | 282,532 | -156,537 |
| PPE Investments | -551 | -412 | -2,045 | -3,690 | -1,387 |
| Net Acquisitions | N/A | N/A | -311,692 | -298,541 | N/A |
| Purchase Of Investment | N/A | N/A | 12,888 | -15,000 | N/A |
| Investing Cash Flow | $268,729 | $-216,663 | $-81,913 | $-34,699 | $-157,924 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 93,000 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 800 | 0 | N/A |
| Debt Repayment | -402,500 | N/A | -138,315 | 0 | N/A |
| Common Stock Issued | 6,610 | 12,423 | 7,095 | 4,361 | 3,928 |
| Other Financing Activity | -94,990 | -22,900 | 0 | -802 | 0 |
| Financing Cash Flow | $-397,880 | $-10,477 | $-130,420 | $3,559 | $3,928 |
| Beginning Cash Position | 93,120 | 203,434 | 288,640 | 181,381 | 192,248 |
| End Cash Position | 75,054 | 93,120 | 203,434 | 288,640 | 181,381 |
| Net Cash Flow | $-18,066 | $-110,314 | $-85,206 | $107,259 | $-10,867 |
| Free Cash Flow | |||||
| Operating Cash Flow | 111,085 | 116,826 | 127,127 | 138,399 | 143,129 |
| Capital Expenditure | -551 | -412 | -2,045 | -3,690 | -1,387 |
| Free Cash Flow | 110,534 | 116,414 | 125,082 | 134,709 | 141,742 |